Screening neonatale per la fibrosi cistica.

Translated title of the contribution: Neonatal screening for cystic fibrosis

V. Lucidi, A. Lelli, M. Castro, S. Bella, C. Ciuffetti, P. Ravet, M. Orrù, U. Angeloni, P. Angeloni

Research output: Contribution to journalArticlepeer-review


Cystic fibrosis (C.F.), a congenital lethal disease involving many organs, is responsible of chronic pulmonary disease and maldigestion. At the beginning symptoms can be feeble and diagnosis is often delayed, especially in those cases with an isolated pulmonary expression. It is demonstrated that early diagnosis and immediate prophylaxis of pulmonary infections and maldigestion improves survival. Thus a neonatal screening test is required. Although various attempts have been done, dating from 1968, there is no evidence, up to now, of a real utility of neonatal screening tests in C.F. The only test with a minor frequency of false negatives and positives is the RIA trypsin serum dosage to be executed within 3-5 days of life.

Translated title of the contributionNeonatal screening for cystic fibrosis
Original languageItalian
Pages (from-to)445-448
Number of pages4
JournalPediatria Medica e Chirurgica
Issue number5
Publication statusPublished - Sept 1994

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Neonatal screening for cystic fibrosis'. Together they form a unique fingerprint.

Cite this